Search research articles
Contact Us
Filters
Showing results (91-100 of 118) with videos related to
Page
of 12
Sort By:
The British Journal of Dermatology
|
October 31, 2012
An investigation of rheumatoid arthritis loci in patients with early-onset psoriasis validates association of the REL gene
F R Ali, A Barton, R L I Smith, et al.
The British Journal of Dermatology
|
May 13, 2017
Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis
A Blauvelt, K Reich, R B Warren, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 3, 2017
Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials
L Guenther, R B Warren, J C Cather, et al.
Archives of Dermatological Research
|
February 3, 2016
Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis
Rh Ll Smith, H L Hébert, J Massey, et al.
The British Journal of Dermatology
|
August 30, 2018
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
R B Warren, A Marsden, B Tomenson, et al.
The British Journal of Dermatology
|
September 3, 2016
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
I Y K Iskandar, D M Ashcroft, R B Warren, et al.
The British Journal of Dermatology
|
August 16, 2014
Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions
H L Hébert, J Bowes, Rh Ll Smith, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 27, 2018
Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis
L C Coates, L J Savage, H Chinoy, et al.
The British Journal of Dermatology
|
June 21, 2019
Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks
K Reich, R B Warren, L Iversen, et al.
The British Journal of Dermatology
|
March 2, 2019
A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis
Z Z N Yiu, K J Mason, J N W N Barker, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 118) with videos related to
Sort By:
Page
of 12
The British Journal of Dermatology
|
October 31, 2012
An investigation of rheumatoid arthritis loci in patients with early-onset psoriasis validates association of the REL gene
F R Ali, A Barton, R L I Smith, et al.
The British Journal of Dermatology
|
May 13, 2017
Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis
A Blauvelt, K Reich, R B Warren, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 3, 2017
Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials
L Guenther, R B Warren, J C Cather, et al.
Archives of Dermatological Research
|
February 3, 2016
Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis
Rh Ll Smith, H L Hébert, J Massey, et al.
The British Journal of Dermatology
|
August 30, 2018
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
R B Warren, A Marsden, B Tomenson, et al.
The British Journal of Dermatology
|
September 3, 2016
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
I Y K Iskandar, D M Ashcroft, R B Warren, et al.
The British Journal of Dermatology
|
August 16, 2014
Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions
H L Hébert, J Bowes, Rh Ll Smith, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 27, 2018
Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis
L C Coates, L J Savage, H Chinoy, et al.
The British Journal of Dermatology
|
June 21, 2019
Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks
K Reich, R B Warren, L Iversen, et al.
The British Journal of Dermatology
|
March 2, 2019
A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis
Z Z N Yiu, K J Mason, J N W N Barker, et al.
Page
of 12